This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical features

Authoring team

After the prodromal period, patients develop objective signs of CNS disease:

  • hyperactivity
    • classically seen intermittently, short periods (1-5 minutes) of agitation, thrashing, running, or other bizarre behaviour alternate with periods of calmness where the patient is cooperative and oriented (maybe anxious)
    • hyperactivity episodes may occur spontaneously or precipitated by tactile, auditory, visual or other stumuli.
  • disorientation
  • hallucinations
  • seizures
  • bizarre behaviour
  • hydrophobia or aerophobia
    • attempt to drink water results in severe spasms of the pharynx and larynx which may lead to choking, gagging and fear. Hence these symptoms may be precipitated when the patient sees water or has air blown on the face.
  • nuchal stiffness
  • fever
  • fasciculations of the muscles
  • hypersalivation
  • paralysis

Clinical examination reveals hypereflexia, spasticity, and evidence of sympathetic overactivity indicated by pupillary dilatation and diaphoresis.

There is development of convulsions, respiratory paralysis and cardiac arrhythmias. Death usually occurs in 10-14 days from onset of neurological dysfunction if no intensive care is instituted.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.